###begin article-title 0
Converging Pharmacological and Genetic Evidence Indicates a Role for Steroid Sulfatase in Attention
###end article-title 0
###begin p 1
This document may be redistributed and reused, subject to .
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 245 248 245 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STS</italic>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
###xml 206 212 <span type="species:ncbi:9606">humans</span>
Attention-deficit/hyperactivity disorder (ADHD) is a complex neurodevelopmental disorder characterized by deficits in attention, increased motor impulsivity, and hyperactivity. Preliminary work in mice and humans has suggested the X-linked gene STS (which encodes the enzyme steroid sulfatase) as a mediator of attentional functioning and as a candidate gene for ADHD.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 273 274 273 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 30 36 <span type="species:ncbi:10090">murine</span>
###xml 277 281 <span type="species:ncbi:10090">mice</span>
The effects of modulating the murine steroid sulfatase axis pharmacologically (through administration of the substrate dehydroepiandrosterone sulfate [DHEAS], 0-40mg/kg, or acute inhibition of the enzyme by COUMATE, 10mg/kg) or genetically (through loss of the gene in 39,XY*O mice) were assayed using the 5-choice serial reaction time task (5-CSRTT) a test of visuospatial attention and response control, and a locomotor activity paradigm.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 182 185 182 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sts</italic>
###xml 242 243 242 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 246 250 <span type="species:ncbi:10090">mice</span>
DHEAS administration improved 5-CSRTT performance under attentionally demanding conditions, whereas steroid sulfatase inhibition impaired accuracy under the same conditions. Loss of Sts expression constitutively throughout development in 39,XY*O mice resulted in deficits in 5-CSRTT performance at short stimulus durations and reduced anticipatory responding. Neither the pharmacologic nor the genetic manipulations affected basic locomotor activity.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 277 280 277 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STS</italic>
These data provide converging evidence indicating a role for steroid sulfatase in discrete aspects of attentional functioning and are suggestive of a role in motor impulsivity. The findings provide novel insights into the neurobiology of attention and strengthen the notion of STS as a candidate gene for the attentional component of ADHD.
###end p 9
###begin title 10
Key Words
###end title 10
###begin p 11
###xml 169 170 169 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib1" ref-type="bibr">1</xref>
###xml 251 252 251 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib2" ref-type="bibr">2</xref>
###xml 308 309 308 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib3" ref-type="bibr">3</xref>
###xml 393 394 393 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib4" ref-type="bibr">4</xref>
###xml 447 450 447 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib5 bib6 bib7" ref-type="bibr">5&#8211;7</xref>
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by deficits in attention, hyperactivity, and increased motor impulsivity (1). Although environmental factors may play a role in precipitating the disorder (2), there is also a strong underlying genetic component (3). Diagnosis of ADHD is approximately 4 times more common in males than in females (4), and the etiology of the disorder is sex-specific (5-7); therefore, genes on the sex chromosomes may influence susceptibility.
###end p 11
###begin p 12
###xml 259 263 259 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib8 bib9 bib10" ref-type="bibr">8&#8211;10</xref>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib11" ref-type="bibr">11</xref>
###xml 475 477 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12" ref-type="bibr">12</xref>
###xml 515 516 515 516 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X</sup>
###xml 593 594 593 594 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X</sup>
###xml 696 697 696 697 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X</sup>
###xml 744 747 744 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sts</italic>
###xml 896 898 896 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12" ref-type="bibr">12</xref>
###xml 925 928 925 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STS</italic>
###xml 953 955 953 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib13" ref-type="bibr">13</xref>
###xml 366 370 <span type="species:ncbi:10090">mice</span>
###xml 517 521 <span type="species:ncbi:10090">mice</span>
###xml 541 545 <span type="species:ncbi:10090">mice</span>
###xml 632 636 <span type="species:ncbi:10090">mice</span>
###xml 904 910 <span type="species:ncbi:9606">humans</span>
###xml 918 923 <span type="species:ncbi:10090">mouse</span>
Evidence for an X-linked gene influencing attention has come from work in Turner syndrome (TS) subjects. Individuals with TS are females who, most typically, lack a whole X chromosome. They are impaired on neuropsychological and real-life tests of attention (8-10) and are at increased ADHD risk relative to 46,XX subjects (11). We have previously shown that female mice with a single X chromosome (39,XO) also show attentional deficits relative to their 40,XX litter mates (12). Additionally, we showed that 40,XY*X mice (essentially 39,XO mice bearing a small number of extra genes on the Y*X chromosome) do not differ from 40,XX mice in terms of their attentional performance, implying that Y*X genes can influence attention. We argued that Sts, encoding the enzyme steroid sulfatase, represents the best candidate for this "rescue" effect on the basis of its expression pattern and function (12). In humans, as in mouse, STS escapes X-inactivation (13); thus, it may be regarded as a candidate gene for the TS attentional deficits.
###end p 12
###begin p 13
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib14" ref-type="bibr">14</xref>
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib15" ref-type="bibr">15</xref>
###xml 264 267 264 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sts</italic>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib16" ref-type="bibr">16</xref>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib17" ref-type="bibr">17</xref>
###xml 462 465 462 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STS</italic>
###xml 497 499 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib18" ref-type="bibr">18</xref>
###xml 811 816 811 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib19 bib20" ref-type="bibr">19,20</xref>
###xml 965 967 953 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib21" ref-type="bibr">21</xref>
###xml 251 256 <span type="species:ncbi:10090">mouse</span>
###xml 454 460 <span type="species:ncbi:9606">humans</span>
###xml 822 826 <span type="species:ncbi:10090">mice</span>
Steroid sulfatase converts various sulfated compounds to their nonsulfated forms, notably the neurosteroid dehydroepiandrosterone sulfate (DHEAS) to DHEA (14); DHEAS and DHEA have important effects on neural function, including cognition (15). In the mouse brain, Sts is most highly expressed in the cortex, hindbrain, and thalamus, with lower expression elsewhere (16). Levels peak around the perinatal period and are relatively low thereafter (17). In humans, STS is expressed in the neocortex (18). Steroid sulfatase influences the malignancy of hormone-dependent cancers (probably by enhancing the availability of free steroid precursors). Consequently, substantial effort has been invested in developing specific inhibitors of the enzyme for therapy, for example, the arylsulfamate-based compound COUMATE (19,20). In mice, systemic COUMATE administration results in profound attenuation (approximately 70%) of brain steroid sulfatase activity within 24 hours (21).
###end p 13
###begin p 14
###xml 30 33 30 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STS</italic>
###xml 204 209 204 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib22 bib23 bib24 bib25" ref-type="bibr">22&#8211;25</xref>
###xml 825 827 825 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib26" ref-type="bibr">26</xref>
###xml 945 946 945 946 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 960 962 960 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib27" ref-type="bibr">27</xref>
###xml 1000 1001 1000 1001 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 1159 1162 1159 1162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sts</italic>
###xml 1228 1230 1228 1230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib28" ref-type="bibr">28</xref>
###xml 1233 1241 1233 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Figure 1</xref>
###xml 568 573 <span type="species:ncbi:10090">mouse</span>
###xml 647 651 <span type="species:ncbi:10090">mice</span>
###xml 954 958 <span type="species:ncbi:10090">mice</span>
###xml 1004 1008 <span type="species:ncbi:10090">mice</span>
Previous data have implicated STS in ADHD risk: males with cytogenetic deletions encompassing the gene (or with inactivating mutations within it) appear to show an enhanced vulnerability to the disorder (22-25). However, the pleiotropic effects of multiple gene deletions, the small sample sizes used, and the lack of appropriate control samples means that the conclusions of these studies should be interpreted cautiously. We directly tested the hypothesis that steroid sulfatase could influence ADHD endophenotypes (attention, motor impulsivity, and activity) using mouse models. Two approaches were employed: in a pharmacologic approach, adult mice were given DHEAS or COUMATE to ascertain the effects of acute manipulation of the steroid sulfatase axis. Because ADHD can persist into adulthood with adverse consequences (26), such an approach could shed light on the molecular pathogenesis of adult ADHD. In a parallel genetic approach, 39,XY*O male mice (27) were compared with 40,XY males. 39,XY*O mice have a single large sex chromosome comprising the X and Y attached via an end-to-end fusion of their pseudoautosomal regions, with both copies of the Sts gene deleted but a normal complement of all other X and Y genes (28) [Figure 1). Using this model, the effects of loss of steroid sulfatase function throughout development could be determined.
###end p 14
###begin p 15
###xml 78 80 78 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib29" ref-type="bibr">29</xref>
###xml 612 614 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib30" ref-type="bibr">30</xref>
Attention was assayed using the 5-choice serial reaction time task (5-CSRTT) (29) in which subjects must respond as accurately and as rapidly as possible with a directed nose-poke response to the presentation of a light stimulus presented pseudo-randomly in one of five spatial locations to gain a reinforcer. This task also provides an index of motor impulsivity in that it is possible to measure the ability of the subjects to withhold responding in a pause (the "intertrial interval") before the onset of the stimulus. The neural substrates underlying 5-CSRTT performance have been well specified in rodents (30).
###end p 15
###begin p 16
###xml 39 41 39 41 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12" ref-type="bibr">12</xref>
On the basis of our previous findings (12), the main prediction at the outset of the experiments was that pharmacologic or genetic manipulations (or both) influencing the steroid sulfatase axis would result in alterations in attention.
###end p 16
###begin title 17
Methods and Materials
###end title 17
###begin title 18
Subjects
###end title 18
###begin p 19
###xml 187 188 187 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 339 340 339 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 393 396 393 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Paf</italic>
###xml 393 396 393 396 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>Paf</italic></sup>
###xml 415 418 415 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Paf</italic>
###xml 415 418 415 418 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>Paf</italic></sup>
###xml 426 427 426 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 435 447 435 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec5" ref-type="sec">Supplement 1</xref>
###xml 636 648 636 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec5" ref-type="sec">Supplement 1</xref>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 196 200 <span type="species:ncbi:10090">mice</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 501 505 <span type="species:ncbi:10090">Mice</span>
For the pharmacologic study, we used male MF1 mice (Harlan, Bicester, United Kingdom). Behavioral testing commenced at approximately 5 months of age. For the genetic study, 40,XY and 39,XY*O male mice on identical genetic backgrounds were imported from Medical Research Council National Institute for Medical Research, United Kingdom. 39,XY*O mice were produced from two separate crosses: 39,XPafO x 40,XY* and 39,XPafO x 39,XY*O (see Supplement 1). Behavioral testing commenced at 4-6 months of age. Mice were treated in accordance with the Animal Scientific Procedures Act (United Kingdom, 1986). For details of animal husbandry, see Supplement 1.
###end p 19
###begin title 20
Reinforcer Preference, 5-CSRTT Training to Stable Baseline Performance
###end title 20
###begin p 21
###xml 63 65 63 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib29" ref-type="bibr">29</xref>
###xml 428 430 428 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12" ref-type="bibr">12</xref>
###xml 442 454 442 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec5" ref-type="sec">Supplement 1</xref>
###xml 498 502 <span type="species:ncbi:10090">mice</span>
Reinforcer preference was carried out as described previously (29), with the main index of preference being the amount of reinforcer (10% condensed milk solution, Nestle, Croydon, United Kingdom) drunk on the final day of preference testing as a percentage of total fluid consumption (choice between water and reinforcer). The 5-CSRTT apparatus, behavioral shaping, trial design, and training are described in detail elsewhere (12) (see also Supplement 1). At baseline stimulus durations of 1 sec, mice performed more than 50 trials at greater than 80% accuracy (i.e., correct:incorrect responses) and less than 30% omissions (i.e., no response to stimulus presentation); the intertrial interval (ITI) was set to 5 sec.
###end p 21
###begin title 22
5-CSRTT Manipulations
###end title 22
###begin p 23
###xml 989 994 987 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12 bib29" ref-type="bibr">12,29</xref>
At stable baseline performance (baseline criteria for >/= 5 consecutive days), three behavioral manipulations designed to affect different aspects of attentional load/impulse control were performed with 2 or more days of consecutive baseline performance between each manipulation session: 1) short stimulus durations (.25, .5, .75 and 1.0 sec), 2) extra-short stimulus durations (.1, .3, .5, and .7 sec; short stimulus durations increasing attentional load), and 3) long ITI (5, 6, 7, and 8 sec; long ITIs taxing the ability to withhold responding). During manipulation sessions, the various parameters were presented pseudo-randomly. Where relevant, following completion of these manipulation sessions in the 5-CSRTT, the extent to which any effects on behavior could be attributed to attentional processes was further assessed in a 1-choice version of the task (1-CSRTT) in which attentional demands of the task were reduced by only presenting the stimulus in the central response hole (12,29). Stimulus duration manipulations were performed after five or more sessions at criterion on the modified task.
###end p 23
###begin title 24
Behavioural Measures on the 5-CSRTT/1-CSRTT
###end title 24
###begin p 25
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib30" ref-type="bibr">30</xref>
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib30" ref-type="bibr">30</xref>
The following behavioral measures were recorded: number of trials, accuracy and omissions, (indexing failures of detection and/or motivational/motor deficits) (30), number of premature responses (i.e., nose pokes made in the ITI before stimulus presentation, indexing motor impulsivity) (30), correct response latency (defined as the time taken to nose poke in the illuminated hole following stimulus onset), and the latency to collect and consume the reinforcer.
###end p 25
###begin title 26
Pharmacological Analysis in the 5-CSRTT/1-CSRTT
###end title 26
###begin p 27
###xml 122 123 122 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 545 550 545 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib21 bib31" ref-type="bibr">21,31</xref>
###xml 867 868 867 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1069 1071 1069 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib21" ref-type="bibr">21</xref>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 215 220 <span type="species:ncbi:10090">mouse</span>
###xml 539 543 <span type="species:ncbi:10090">mice</span>
###xml 572 577 <span type="species:ncbi:10090">mouse</span>
###xml 737 741 <span type="species:ncbi:10090">mice</span>
###xml 861 865 <span type="species:ncbi:10090">mice</span>
###xml 1202 1206 <span type="species:ncbi:10090">mice</span>
In the first part of the pharmacologic study, DHEAS (Sigma-Aldrich, Gillingham, United Kingdom) was administered to mice (n = 12) at stable baseline performance on the 5-CSRTT 1 hour before behavioral testing. Each mouse received four doses of drug (0, 5, 15, and 40 mg/kg in distilled water intraperitoneal [i.p.]) with at least 72 hours washout between treatments; the order in which the doses were given was pseudo-randomized to negate possible order effects. The drug doses selected have previously been shown to influence behavior in mice (21,31). Subsequently, each mouse was given either vehicle or 40 mg/kg DHEAS (pseudo-randomized) and tested specifically on the 5-CSRTT short-stimulus-duration manipulation; following washout, mice were given the opposite drug/vehicle treatment and retested on the task manipulation. In the second part of the study, mice (n = 12) were pseudo-randomly injected either with vehicle (.5% methylcellulose, .9% NaCl in distilled water per os [p.o.]) or with COUMATE (10 mg/kg in the same vehicle p.o., COUMATE made according to [21]) 24 hours before behavioral testing on the short-stimulus-duration manipulation in the 5-CSRTT. After at least 72 hours washout, mice were given the opposite drug/vehicle treatment and retested. The effects of COUMATE administration were then tested in the 1-CSRTT under the same conditions.
###end p 27
###begin title 28
Locomotor Activity
###end title 28
###begin p 29
###xml 274 275 274 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 595 596 595 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 611 612 611 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 616 617 616 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 688 691 688 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sts</italic>
###xml 105 109 <span type="species:ncbi:10090">Mice</span>
###xml 268 272 <span type="species:ncbi:10090">mice</span>
###xml 534 538 <span type="species:ncbi:10090">mice</span>
###xml 624 628 <span type="species:ncbi:10090">mice</span>
Locomotor activity was measured in dim lighting (5 lux) using cages each fitted with two infrared beams. Mice were allowed to explore freely for a 1-hour session, with the number of individual infrared beam breaks indexing their activity. For the pharmacologic study, mice (n = 7) were run for 6 days (1 session per day) to habituate them to the apparatus and to limit any interactions between drug treatment and reactivity to novelty. They were then treated with either vehicle or COUMATE 24 hours before testing. After washout, the mice were given the opposite treatment and rerun. The 40,XY (n = 20) and 39,XY*O (n = 14) mice were run on 3 consecutive days to ascertain the effects of Sts loss on reactivity to a novel environment and basic locomotor activity.
###end p 29
###begin title 30
Statistical Analysis
###end title 30
###begin p 31
###xml 70 71 70 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 217 218 217 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 272 273 272 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 294 295 294 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 527 529 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib32" ref-type="bibr">32</xref>
###xml 701 702 701 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Statistical analysis was performed using SPSS12. Data were subject to t test or repeated-measures analysis of variance (ANOVA) if normal, with factors Drug Treatment/Genotype and Task Manipulation/Day or Mann-Whitney U test and Wilcoxon Signed-Ranks test (if not normal). t tests, Mann-Whitney U tests, and Wilcoxon Signed-Ranks tests were used to analyze overall performance in the task. Percentage data (accuracy and omissions) and premature response data were arcsine or square root transformed, respectively, before ANOVA (32). If ANOVA indicated a significant interaction between factors, post hoc pairwise comparisons were performed using Tukey's honestly significant difference test. Values of p < .05 were regarded as significant. The results were not corrected for multiple testing. Data are presented as mean values +/- standard error of the mean.
###end p 31
###begin title 32
Results
###end title 32
###begin title 33
Pharmacologic Study
###end title 33
###begin title 34
DHEAS Does Not Influence Baseline Performance in the 5-CSRTT
###end title 34
###begin p 35
###xml 128 140 128 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec5" ref-type="sec">Supplement 1</xref>
DHEAS administration at any of the doses tested did not significantly affect the main 5-CSRTT performance measures at baseline (Supplement 1).
###end p 35
###begin title 36
DHEAS Reduces Omissions Under Attentionally Demanding Conditions
###end title 36
###begin p 37
###xml 247 248 247 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 265 273 265 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Figure 2</xref>
###xml 324 325 324 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 379 380 379 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 398 406 398 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Figure 2</xref>
###xml 626 627 626 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 642 643 642 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 682 683 682 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 691 699 691 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Figure 2</xref>
###xml 804 805 804 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 859 860 859 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 878 886 878 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Figure 2</xref>
###xml 956 957 956 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
We tested whether the highest dose of DHEAS (40 mg/kg) would influence behavior under more attentionally demanding conditions (i.e., attenuated stimulus durations). As at baseline, DHEAS administration did not affect trial number [Drug Treatment, t(11) = -.58, ns, Figure 2A], nor did it influence accuracy [Drug Treatment, F(1,11) = .03, ns, Drug Treatment x Task Manipulation, F(3,33) = .82, ns, Figure 2B]. However, DHEAS treatment did appear to enhance task performance specifically at the shortest stimulus duration of .25 sec, as reflected in the significant Drug Treatment x Task Manipulation interaction on omissions [F(3,33) = 3.23, p = .035] and subsequent post hoc test (p < .05; Figure 2C). DHEAS did not affect correct response latency under the shorter stimulus conditions [Drug Treatment, F(1,11) = .76, ns, Drug Treatment x Task Manipulation, F(3,33) = .25, ns, Figure 2D], nor the total number of premature responses made [Drug Treatment, t(11) = -1.34, ns].
###end p 37
###begin title 38
COUMATE Impairs Accuracy in the 5-CSRTT Under Attentionally Demanding Conditions; This Impairment Is Alleviated in the 1-CSRTT
###end title 38
###begin p 39
###xml 126 127 126 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 142 143 142 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 285 286 285 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 301 302 301 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 342 343 342 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 351 359 351 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Figure 3</xref>
###xml 492 493 492 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 511 519 511 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Figure 3</xref>
###xml 534 535 534 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 589 590 589 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 609 617 609 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Figure 3</xref>
###xml 647 648 647 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 702 703 702 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 721 729 721 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Figure 3</xref>
###xml 972 973 968 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 995 996 991 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
COUMATE administration resulted in significantly decreased accuracy under short-stimulus-duration conditions [Drug Treatment, F(1,11) = 8.87, p = .013]; this deficit in accuracy was particularly pronounced at the shortest .25-sec stimulus duration [Drug Treatment x Task Manipulation, F(3,33) = 3.79, p = .019, subsequent pairwise comparison p < .01; Figure 3B]. The effects of the drug manipulation were behaviorally specific in that there were no effects of Drug Treatment on trial number [t(11) = -1.34, ns, Figure 3A), omissions [F(1,11) = .01, ns, Drug Treatment x Task Manipulation, F(3,33) = 1.47, ns, Figure 3C], correct response latency [F(1,11) = .14, ns, Drug Treatment x Task Manipulation, F(3,33) = .11, ns, Figure 3D] or total number of premature responses (Vehicle vs. COUMATE, 3.2 +/- 1.0 vs. 5.2 +/- 1.6, W = -27, Z = -1.33, ns). Furthermore, Drug Treatment did not influence two measures of motivation: the latency to collect and consume the reinforcer [F(1,11) = .18, ns, and F(1,11) = .25, ns, respectively].
###end p 39
###begin p 40
###xml 236 237 224 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 291 292 279 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 310 318 298 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Figure 3</xref>
###xml 376 377 364 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 435 436 423 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 483 484 471 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 538 539 526 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
Baseline performance on the 1-CSRTT was, as expected, superior to that on the 5-CSRTT (accuracy: > 95%, omissions: < 15%, correct response latency: approximately.85 sec). In the 1-CSRTT, COUMATE did not affect accuracy [Drug Treatment, F(1,11) = .02, ns; Drug Treatment x Task Manipulation, F(3,33) = .89, ns; Figure 3E]. There were no effects of Drug Treatment on omissions [F(1,11) = .00, ns, and Drug Treatment x Task Manipulation, F(3,33) = .70, ns] or correct response latency [F(1,11) = .89, ns, Drug Treatment x Task Manipulation, F(3,33) = .56, ns].
###end p 40
###begin title 41
Genetic Study
###end title 41
###begin title 42
###xml 14 15 14 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 18 22 <span type="species:ncbi:10090">Mice</span>
40,XY and 39,XY*O Mice Demonstrate Equivalent Reinforcer Preference, 5-CSRTT Acquisition, and Baseline Performance
###end title 42
###begin p 43
###xml 11 12 11 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 26 27 26 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 31 32 31 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 209 210 205 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 373 374 365 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 418 419 410 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 461 468 453 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">Table 1</xref>
###xml 488 489 480 481 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
###xml 422 426 <span type="species:ncbi:10090">mice</span>
###xml 492 496 <span type="species:ncbi:10090">mice</span>
The 40,XY (n = 9) and 39,XY*O (n = 12) mice were trained to performance criteria in the 5-CSRTT. The groups displayed equivalent reinforcer preference [78.8 +/- 5.5% vs. 84.7 +/- 4.8%, respectively, GENOTYPE, t(19) = -.81, ns] and acquired the task in an equal number of sessions, indicating no effects of Genotype on learning [68.4 +/- 8.1 vs. 63.6 +/- 8.8, respectively, t(19) = .39, ns]. At baseline, 40,XY and 39,XY*O mice generally performed equivalently (Table 1), although the 39,XY*O mice adopted a more efficient response strategy, performing fewer nose pokes per trial than 40,XY subjects.
###end p 43
###begin title 44
###xml 4 5 4 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 8 12 <span type="species:ncbi:10090">Mice</span>
###xml 56 60 <span type="species:ncbi:10090">Mice</span>
39,XY*O Mice Show Increased Omissions Relative to 40,XY Mice Under Attentionally Demanding Conditions; This Group Difference Is Abolished in the 1-CSRTT
###end title 44
###begin p 45
###xml 71 72 71 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 442 443 442 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 465 466 465 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 534 535 534 535 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 647 648 647 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 812 813 812 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 828 829 828 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 920 921 920 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 929 937 929 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Figure 4</xref>
###xml 1063 1064 1063 1064 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1082 1090 1082 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Figure 4</xref>
###xml 1120 1121 1120 1121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1169 1170 1169 1170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1188 1196 1188 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Figure 4</xref>
###xml 1235 1236 1235 1236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1285 1286 1285 1286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1345 1346 1345 1346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1395 1396 1395 1396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1520 1521 1520 1521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1597 1598 1597 1598 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 1680 1681 1680 1681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1700 1708 1700 1708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Figure 4</xref>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 538 542 <span type="species:ncbi:10090">mice</span>
###xml 577 581 <span type="species:ncbi:10090">mice</span>
To further tax attention, we compared the performance of 40,XY and 39,XY*O mice on two manipulations in which stimulus durations were attenuated: one with stimulus durations ranging from 1.0 to .25 sec and a second, more attentionally demanding manipulation, with stimulus durations ranging from .7 to .1 s. On the first manipulation, there was no effect of Genotype with respect to the two main indices of attention, accuracy and omissions [F(1,19) = .31, ns, and F(1,19) = .00, ns, respectively], although there was a trend for 39,XY*O mice to make more omissions than 40,XY mice at the shortest stimulus duration (Genotype x Task Manipulation, F(3,57) = 1.54, ns]. On the second manipulation, this effect on omissions was more pronounced, giving rise to a significant Genotype x Task Manipulation interaction F(3,57) = 4.53, p < .01] and a significant pairwise comparison at the shortest stimulus duration of .1 sec (p < .01; Figure 4C). Importantly, this effect occurred in the absence of any Genotype effects on markers of motivation including trial number [t(19) = -1.07, ns, Figure 4A], correct response latency [F(1,19) = .43, ns, Genotype x Task Manipulation, F(3,57) = .45, ns, Figure 4D], latency to collect the reinforcer [F(1,19) = 1.39, ns, Genotype x Task Manipulation, F(3,57) = 1.38, ns], and latency to consume the reinforcer [F(1,19) = 1.46, ns, Genotype x Task Manipulation, F(3,57) = 2.02, ns]. Although accuracy did not differ significantly between genotypes on this latter manipulation [Genotype, F(1,19) = .02, ns], there was a trend toward impaired performance in the 39,XY*O group at the shortest stimulus duration of .1 s [Genotype x Task Manipulation, F(3,57) = 1.71, ns, Figure 4B].
###end p 45
###begin p 46
###xml 38 39 38 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 114 121 114 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl2" ref-type="table">Table 2</xref>
###xml 220 221 220 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 270 271 270 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 289 297 289 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Figure 4</xref>
###xml 434 435 434 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 484 485 484 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 517 518 517 518 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 629 630 629 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 645 646 645 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 684 685 684 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 885 886 885 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 901 902 901 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 934 935 934 935 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 1026 1027 1026 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1042 1043 1042 1043 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1081 1082 1081 1082 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1100 1108 1100 1108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">Figure 5</xref>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
###xml 521 525 <span type="species:ncbi:10090">mice</span>
###xml 613 617 <span type="species:ncbi:10090">mice</span>
###xml 938 942 <span type="species:ncbi:10090">mice</span>
###xml 988 992 <span type="species:ncbi:10090">mice</span>
Baseline performance of 40,XY and 39,XY*O mice in the 1-CSRTT was equivalent and superior to that in the 5-CSRTT (Table 2). In the 1-CSRTT, there were no stimulus duration-dependent group effects on omissions [Genotype, F(1,19) = 3.15, ns; Genotype x Task Manipulation, F(3,57) = .97, ns, Figure 4E]. Furthermore, accuracy did not differ significantly between the groups on the 1-CSRTT short-stimulus-duration manipulation [Genotype, F(1,19) = 1.18, ns; Genotype x Task Manipulation, F(3,57) = .13, ns]. However, 39,XY*O mice tended to respond correctly more slowly for all values of stimulus duration than 40,XY mice [Genotype, F(1,19) = 5.66, p = .03, Genotype x Task Manipulation, F(3,57) = 1.47, ns]. The only other significant effect of Genotype was in the "long ITI" 5-CSRTT manipulation. As expected, premature responding increased with increased ITI length [Task Manipulation, F(3,57) = 6.92, p < .0005], but unexpectedly 39,XY*O mice made fewer anticipatory responses than 40,XY mice for all values of ITI [Genotype, F(1,19) = 4.39, p = .05, Genotype x Task Manipulation, F(3,57) = .32, ns, Figure 5] suggesting that the former group display a reduced tendency for impulsive responding.
###end p 46
###begin title 47
Steroid Sulfatase Manipulations Do Not Affect Locomotor Activity
###end title 47
###begin p 48
###xml 81 82 81 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 96 104 96 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig6" ref-type="fig">Figure 6</xref>
###xml 149 150 149 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 222 223 222 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 257 258 257 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 277 285 277 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig6" ref-type="fig">Figure 6</xref>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
COUMATE treatment did not have any effect on locomotor activity [Drug Treatment, t(6) = .8, ns, Figure 6A]. Initial activity levels of 40,XY and 39,XY*O mice were identical and decreased equally across sessions [Genotype: F(1,32) = .45, ns; Genotype x DAY: F(2,64) = 1.85, ns, Figure 6B].
###end p 48
###begin title 49
Discussion
###end title 49
###begin p 50
###xml 96 99 96 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STS</italic>
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib15" ref-type="bibr">15</xref>
###xml 185 190 185 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12 bib23" ref-type="bibr">12,23</xref>
###xml 259 264 <span type="species:ncbi:10090">mouse</span>
Previous studies have suggested that the enzyme steroid sulfatase, encoded by the X-linked gene STS, and a modulator of neuroactive steroid activity (15), may play a role in attention (12,23). We tested this idea using pharmacologic and genetic approaches in mouse models.
###end p 50
###begin p 51
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12" ref-type="bibr">12</xref>
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib33" ref-type="bibr">33</xref>
###xml 683 685 683 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib34" ref-type="bibr">34</xref>
###xml 788 790 788 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib35" ref-type="bibr">35</xref>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
###xml 644 652 <span type="species:ncbi:9606">patients</span>
We hypothesized that haploinsufficiency for steroid sulfatase could account for attentional deficits in 39,XO mice through limiting the conversion of DHEAS to DHEA (12). Hence, we expected that DHEAS administration (which leads to a rise in brain DHEAS and DHEA within 1 hour) (33) may act to improve aspects of attention. DHEAS administration did indeed improve 5-CSRTT performance at the shortest stimulus duration. Whether it is DHEAS or one of its downstream metabolites (e.g., DHEA or androstenediol) that causes this effect remains to be clarified, but this finding is consistent with work showing that DHEA augmentation in schizophrenic patients improves sustained attention (34). Because methylphenidate treatment has been shown to increase systemic DHEA levels in ADHD subjects (35), we propose that DHEA administration may also improve attentional function in ADHD.
###end p 51
###begin p 52
###xml 140 145 <span type="species:ncbi:10090">mouse</span>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
###xml 180 184 <span type="species:ncbi:10090">mice</span>
###xml 286 290 <span type="species:ncbi:10090">mice</span>
###xml 610 614 <span type="species:ncbi:10090">mice</span>
We further anticipated that inhibition of steroid sulfatase would elicit deficits on the 5-CSRTT that recapitulated those seen in the 39,XO mouse. Like 39,XO mice, COUMATE-treated mice showed specific impairments in accuracy at short stimulus durations on the 5-CSRTT, and, as in 39,XO mice, these drug-induced deficits were rescued in the less attentionally demanding 1-CSRTT. Together these findings suggest that steroid sulfatase influences ongoing attentional processes. Moreover, the data indicate that steroid sulfatase plays a similar role in attention in both male (COUMATE-treated) and female (39,XO) mice.
###end p 52
###begin p 53
###xml 8 9 8 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 323 324 323 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 881 882 881 882 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 12 16 <span type="species:ncbi:10090">mice</span>
###xml 266 270 <span type="species:ncbi:10090">mice</span>
###xml 327 331 <span type="species:ncbi:10090">mice</span>
###xml 364 368 <span type="species:ncbi:10090">mice</span>
###xml 429 433 <span type="species:ncbi:10090">mice</span>
###xml 885 889 <span type="species:ncbi:10090">mice</span>
The 39,XY*O mice, which lack steroid sulfatase expression throughout development, demonstrated impaired 5-CSRTT performance (significantly increased omissions and a nonsignificant trend toward impaired accuracy at short stimulus durations) relative to 40,XY control mice; these deficits were rescued in the 1-CSRTT. As 39,XY*O mice performed equivalently to 40,XY mice at longer stimulus durations, and because the two groups of mice were equally motivated, these results may again reasonably be interpreted as a specific impairment in attention. These data, together with previous findings in other models, support the conclusion that alterations in steroid sulfatase function can lead to specific changes in performance on the 5-CSRTT and that these changes are likely to reflect attentional effects. Future work may assess the effects of DHEAS and COUMATE administration in 39,XY*O mice on 5-CSRTT performance to determine the extent to which the behavioral effects mediated by these compounds are truly Sts-dependent.
###end p 53
###begin p 54
###xml 150 153 150 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sts</italic>
###xml 166 167 166 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 355 358 355 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sts</italic>
###xml 615 617 615 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib36" ref-type="bibr">36</xref>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 170 174 <span type="species:ncbi:10090">mice</span>
We note the discrepancy between the measures influenced by acute inhibition of steroid sulfatase in COUMATE-treated mice and constitutive loss of the Sts gene in 39,XY*O mice (effects on accuracy and omissions, respectively). Such a discrepancy may arise because of enzyme inhibition via COUMATE causing acute, and only partial, loss of function, whereas Sts deletion causes complete loss of the enzyme throughout development. Interestingly, a similar dissociation between the effects of acute pharmacologic and genetic manipulations of the cholinergic axis on accuracy and omissions has been described previously (36). Although both accuracy and omissions may be regarded as indices of attention, the precise relationship between the two measures, and the extent to which they index common psychology and neurobiology in rodents, is unclear.
###end p 54
###begin p 55
###xml 256 259 256 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sts</italic>
###xml 267 268 267 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 522 524 522 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib11" ref-type="bibr">11</xref>
###xml 612 615 612 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sts</italic>
###xml 809 811 809 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib37" ref-type="bibr">37</xref>
###xml 1046 1052 1046 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib38 bib39" ref-type="bibr">38, 39</xref>
###xml 1096 1099 1096 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sts</italic>
###xml 1272 1274 1272 1274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib40" ref-type="bibr">40</xref>
###xml 1507 1509 1507 1509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib41" ref-type="bibr">41</xref>
###xml 1652 1654 1652 1654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib21" ref-type="bibr">21</xref>
###xml 1696 1697 1696 1697 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 271 275 <span type="species:ncbi:10090">mice</span>
###xml 1266 1270 <span type="species:ncbi:10090">mice</span>
###xml 1646 1650 <span type="species:ncbi:10090">mice</span>
###xml 1700 1704 <span type="species:ncbi:10090">mice</span>
We also tested whether steroid sulfatase influences other ADHD endophenotypes. Pharmacologic manipulations of the steroid sulfatase axis had no effect on motor impulsivity (as indexed by the degree of anticipatory responding), whereas constitutive loss of Sts in 39,XY*O mice resulted in both significantly fewer nose pokes per trial and reduced premature responding. Because ADHD is characterized by increased motor impulsivity and because the incidence of hyperactive-impulsive type ADHD in Turner syndrome is elevated (11), these latter results are surprising. The dissociation between acute drug effects and Sts loss may reflect the differential effects of steroid sulfatase on ongoing and developmental processes, respectively. In terms of developmental effects, DHEA is known to influence neurogenesis (37). The dissociable effects of steroid sulfatase manipulations on attention and impulse control suggest that it would be interesting to perform other assays of response inhibition (e.g., stop-signal or delayed reinforcement paradigms) (38, 39). Neither steroid sulfatase inhibition nor Sts loss resulted in effects on locomotor activity. These data, in conjunction with previous data showing an absence of effects of 40mg/kg DHEAS on locomotor activity in mice (40), indicate that steroid sulfatase is unlikely to influence neurobiological pathways underpinning activity. ADHD is often comorbid with conduct disorder and oppositional-defiant disorder, which are typified by heightened aggression (41). In light of this, and bearing in mind that coadmininstration of COUMATE and DHEAS has previously been shown to increase aggression in mice (21), it was interesting to observe that 39,XY*O mice appeared more overtly aggressive than their 40,XY counterparts.
###end p 55
###begin p 56
###xml 87 90 87 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sts</italic>
###xml 187 189 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib16" ref-type="bibr">16</xref>
###xml 567 579 567 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec5" ref-type="sec">Supplement 1</xref>
###xml 449 454 <span type="species:ncbi:10090">mouse</span>
The neurobiological substrates of the behavioral effects described herein are unknown. Sts is expressed predominantly in the thalamus, with lesser expression in the cortex and hindbrain (16). Structural or functional changes in one or more of these brain regions, together with their associated circuitry, may underlie the behavioral effects. We have compared the expression of a number of candidate attentional genes in vehicle and COUMATE-treated mouse frontal cortex and thalamus but have failed to find any significant differences between the two groups to date (Supplement 1).
###end p 56
###begin p 57
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib32" ref-type="bibr">32</xref>
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib42" ref-type="bibr">42</xref>
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib43" ref-type="bibr">43</xref>
###xml 335 336 335 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 825 827 825 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib44" ref-type="bibr">44</xref>
###xml 987 992 987 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib45 bib46 bib47 bib48" ref-type="bibr">45&#8211;48</xref>
###xml 1104 1109 1104 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib49 bib50" ref-type="bibr">49,50</xref>
###xml 3 7 <span type="species:ncbi:10116">rats</span>
###xml 139 143 <span type="species:ncbi:10090">mice</span>
###xml 339 343 <span type="species:ncbi:10090">mice</span>
In rats, lesions of the dorsal anterior cingulate cortex produce specific deficits in accuracy that resemble those seen in COUMATE-treated mice (32), whereas lesions of either the nucleus basalis magnocellularis (42) or the pedunculopontine tegmental nucleus (PPTg) (43) produce a pattern of deficits analogous to that observed in 39,XY*O mice (increased omissions and reduced accuracy at short stimulus durations and reduced premature responding). In rodents, the basal forebrain cholinergic complex (which includes the nucleus basalis magnocellularis) projects directly to the cortex and hippocampus and also to the thalamus, whereas the pontine cholinergic system exerts its influence mainly through intralaminar thalamic nuclei, but it also connects to the basal forebrain and provides a minor innervation of the cortex (44). Hence, our behavioral findings, in combination with previous data indicating links between steroid sulfatase and neurosteroid action on cholinergic systems (45-48), suggest that these manipulations may affect attentional functioning by influencing cholinergic transmission (49,50).
###end p 57
###begin p 58
###xml 187 188 183 184 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 223 225 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib51" ref-type="bibr">51</xref>
###xml 232 235 228 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sts</italic>
###xml 293 294 289 290 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 314 316 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib52" ref-type="bibr">52</xref>
###xml 339 340 335 336 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 415 418 411 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sts</italic>
###xml 647 649 643 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib53" ref-type="bibr">53</xref>
###xml 891 892 887 888 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sub>
###xml 909 911 901 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib54" ref-type="bibr">54</xref>
###xml 992 994 984 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib52" ref-type="bibr">52</xref>
###xml 1116 1118 1101 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib55" ref-type="bibr">55</xref>
###xml 1205 1210 1186 1191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib56 bib57 bib58" ref-type="bibr">56&#8211;58</xref>
###xml 1289 1291 1266 1268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib59" ref-type="bibr">59</xref>
###xml 1403 1405 1376 1378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib60" ref-type="bibr">60</xref>
###xml 1457 1458 1430 1431 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 399 403 <span type="species:ncbi:10116">rats</span>
###xml 490 494 <span type="species:ncbi:10090">mice</span>
###xml 985 990 <span type="species:ncbi:10090">mouse</span>
###xml 1336 1340 <span type="species:ncbi:10090">mice</span>
###xml 1461 1465 <span type="species:ncbi:10090">mice</span>
A modulatory role for the steroid sulfatase axis on attention through gamma-aminobutyric acid(GABA)-ergic function is also possible: DHEAS is a known negative allosteric modulator of GABAA-receptor-gated chloride channels (51), and Sts expression correlates with the expression of certain GABAA receptor subunits (52). Infusion of the GABAA receptor agonist muscimol into the subthalamic nucleus in rats (a site of Sts expression) produces an array of deficits recapitulating those seen in mice with compromised steroid sulfatase function (i.e., reduced accuracy, slowed correct responses, increased omissions and decreased premature responding) (53). Although any suggestion of a mechanistic link between neurosteroid and acetylcholinergic/GABAergic effects on attention is speculative, it may be pertinent that cholinergic neurons of the basal forebrain exhibit high expression of the GABAA alpha3 subunit (54), the expression of which is reduced in the attentionally impaired 39,XO mouse (52). It is also noteworthy that 1) alpha4beta2-type nicotinic receptors can control GABAergic transmission in the thalamus (55), 2) the gene encoding the alpha4 nicotinic receptor subunit is associated with ADHD (56-58), 3) alpha7-type nicotinic receptors may be found on GABAergic interneurones (59), and 4) alpha7 nicotinic receptor knockout mice show attention deficits (increased omissions) in the 5-CSRTT (60). In vivo microdialysis in COUMATE-treated and 39,XY*O mice, coupled with pharmacologic manipulations of the acetylcholinergic and GABAergic systems, could be used to test the idea that steroid sulfatase dysfunction causes attentional deficits through perturbations in these systems.
###end p 58
###begin p 59
###xml 33 36 33 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STS</italic>
###xml 283 286 283 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STS</italic>
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib61" ref-type="bibr">61</xref>
###xml 351 354 351 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STS</italic>
###xml 90 96 <span type="species:ncbi:9606">humans</span>
Our data strengthen the case for STS as a candidate gene for attentional (dys)function in humans and suggest that it would be worthwhile to investigate association between the gene and ADHD endophenotypes. Recent, as yet unreplicated, work does appear to show an association between STS variation and ADHD (61). Our data suggest that variation within STS may be particularly associated with the inattentive subtype of ADHD and underlying differences in the structure or function of the thalamocortical circuitry.
###end p 59
###begin title 60
Supplementary data
###end title 60
###begin p 61
Supplementary material cited in this article is available online.
###end p 61
###begin title 62
Supplementary data
###end title 62
###begin p 63
###xml 0 12 0 12 <title xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="64">Supplement 1</title>
###xml 0 12 0 12 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><title textid="64">Supplement 1</title></caption>
###xml 12 12 12 12 <media xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="mmc1.pdf" mimetype="application" mime-subtype="pdf"/>
###xml 0 12 0 12 <supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="local-data" id="mmc1"><caption><title textid="64">Supplement 1</title></caption><media xlink:href="mmc1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material>
Supplement 1
###end p 63
###begin title 64
Supplement 1
###end title 64
###begin p 65
###xml 47 53 <span type="species:ncbi:9606">People</span>
WD was supported by a Wellcome Trust "Value in People" Fellowship and is currently a Research Councils United Kingdom Fellow in Translational Research in Experimental Medicine. WK was supported by a Genetics Society (United Kingdom) Summer Studentship. LSW is supported by a University of Cardiff LINK Award. We thank Drs. Delia Belelli and Jonathan Fry and Professor Anita Thapar for critical reading of the manuscript and Dr. Jonathan Fry for the gift of COUMATE.
###end p 65
###begin p 66
The authors reported no biomedical financial interests or potential conflicts of interest.
###end p 66
###begin title 67
References
###end title 67
###begin article-title 68
The genetics of attention deficit hyperactivity disorder
###end article-title 68
###begin article-title 69
Environmental risk factors for attention-deficit hyperactivity disorder
###end article-title 69
###begin article-title 70
Genetics of attention deficit/hyperactivity disorder
###end article-title 70
###begin article-title 71
Sex and the suffering brain
###end article-title 71
###begin article-title 72
###xml 60 64 <span type="species:ncbi:9606">boys</span>
###xml 69 74 <span type="species:ncbi:9606">girls</span>
ADHD and gender: Are risks and sequela of ADHD the same for boys and girls?
###end article-title 72
###begin article-title 73
Untreated ADHD in adults: Are there sex differences in symptoms, comorbidity, and impairment?
###end article-title 73
###begin article-title 74
Gender differences in ADHD: Implications for psychosocial treatments
###end article-title 74
###begin article-title 75
###xml 39 44 <span type="species:ncbi:9606">women</span>
Persistent cognitive deficits in adult women with Turner syndrome
###end article-title 75
###begin article-title 76
###xml 24 32 <span type="species:ncbi:9606">children</span>
Behavioral phenotype in children with Turner syndrome
###end article-title 76
###begin article-title 77
###xml 46 54 <span type="species:ncbi:9606">children</span>
Frontal lobe function and executive skills in children with Turner's syndrome
###end article-title 77
###begin article-title 78
Increased prevalence of ADHD in Turner syndrome with no evidence of imprinting effects
###end article-title 78
###begin article-title 79
###xml 48 52 <span type="species:ncbi:10090">mice</span>
X-monosomy effects on visuospatial attention in mice: A candidate gene and implications for Turner syndrome and attention deficit hyperactivity disorder
###end article-title 79
###begin article-title 80
X-inactivation profile reveals extensive variability in X-linked gene expression in females
###end article-title 80
###begin article-title 81
Steroid sulfatase: Molecular biology, regulation, and inhibition
###end article-title 81
###begin article-title 82
###xml 129 135 <span type="species:ncbi:9606">humans</span>
Actions of dehydroepiandrosterone and its sulfate in the central nervous system: Effects on cognition and emotion in animals and humans
###end article-title 82
###begin article-title 83
Expression of steroid sulfatase during embryogenesis
###end article-title 83
###begin article-title 84
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine steroid sulfatase gene expression in the brain during postnatal development and adulthood
###end article-title 84
###begin article-title 85
###xml 42 47 <span type="species:ncbi:9606">human</span>
Steroid sulfatase (STS) expression in the human temporal lobe: Enzyme activity, mRNA expression and immunohistochemistry study
###end article-title 85
###begin article-title 86
Inhibition of steroid sulphatase activity in endometriotic implants by 667 COUMATE: A potential new therapy
###end article-title 86
###begin article-title 87
Steroid sulphatase inhibitors for breast cancer therapy
###end article-title 87
###begin article-title 88
###xml 93 97 <span type="species:ncbi:10090">mice</span>
Aggressive behavior induced by the steroid sulfatase inhibitor COUMATE and by DHEAS in CBA/H mice
###end article-title 88
###begin article-title 89
An Xp; Yq translocation causing a novel contiguous gene syndrome in brothers with generalized epilepsy, ichthyosis, and attention deficits
###end article-title 89
###begin article-title 90
X linked ichthyosis (steroid sulphatase deficiency) is associated with increased risk of attention deficit hyperactivity disorder, autism and social communication deficits
###end article-title 90
###begin article-title 91
###xml 72 75 <span type="species:ncbi:9606">boy</span>
Contiguous gene syndrome due to an interstitial deletion in Xp22.3 in a boy with ichthyosis, chondrodysplasia punctata, mental retardation and ADHD
###end article-title 91
###begin article-title 92
###xml 50 53 <span type="species:ncbi:9606">boy</span>
Absence of learning difficulties in a hyperactive boy with a terminal Xp deletion encompassing the MRX49 locus
###end article-title 92
###begin article-title 93
The consequences of attention-deficit/hyperactivity disorder in adults
###end article-title 93
###begin article-title 94
The meiotic checkpoint monitoring synapsis eliminates spermatocytes via p53-independent apoptosis
###end article-title 94
###begin article-title 95
###xml 24 28 <span type="species:ncbi:10090">mice</span>
The Y* rearrangement in mice: New insights into a perplexing PAR
###end article-title 95
###begin article-title 96
###xml 40 44 <span type="species:ncbi:10090">mice</span>
Visuospatial attentional functioning in mice: Interactions between cholinergic manipulations and genotype
###end article-title 96
###begin article-title 97
The 5-choice serial reaction time task: Behavioural pharmacology and functional neurochemistry
###end article-title 97
###begin article-title 98
Neurosteroids ameliorate conditioned fear stress: An association with sigma receptors
###end article-title 98
###begin article-title 99
###xml 173 176 <span type="species:ncbi:10116">rat</span>
Dissociable aspects of performance on the 5-choice serial reaction time task following lesions of the dorsal anterior cingulate, infralimbic and orbitofrontal cortex in the rat: Differential effects on selectivity, impulsivity and compulsivity
###end article-title 99
###begin article-title 100
###xml 133 138 <span type="species:ncbi:10090">mouse</span>
The steroid sulfatase inhibitor COUMATE attenuates rather than enhances access of dehydroepiandrosterone sulfate to the brain in the mouse
###end article-title 100
###begin article-title 101
Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: A randomized, double-blind, placebo-controlled, crossover trial
###end article-title 101
###begin article-title 102
Three-month treatment course of methylphenidate increases plasma levels of dehydroepiandrosterone (DHEA) and dehydroepiandrosterone-sulfate (DHEA-S) in attention deficit hyperactivity disorder
###end article-title 102
###begin article-title 103
###xml 41 45 <span type="species:ncbi:10090">mice</span>
Nicotine improves sustained attention in mice: Evidence for involvement of the alpha7 nicotinic acetylcholine receptor
###end article-title 103
###begin article-title 104
###xml 80 83 <span type="species:ncbi:10116">rat</span>
Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone-induced suppression
###end article-title 104
###begin article-title 105
The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go/no-go tasks
###end article-title 105
###begin article-title 106
###xml 25 29 <span type="species:ncbi:10090">mice</span>
Measuring impulsivity in mice using a novel operant delayed reinforcement task: Effects of behavioural manipulations and d-amphetamine
###end article-title 106
###begin article-title 107
###xml 142 147 <span type="species:ncbi:10090">mouse</span>
Involvement of sigma (sigma1) receptors in modulating the anti-depressant effect of neurosteroids (dehydroepiandrosterone or pregnenolone) in mouse tail-suspension test
###end article-title 107
###begin article-title 108
ADHD with comorbid oppositional defiant disorder or conduct disorder: Discrete or nondistinct disruptive behavior disorders?
###end article-title 108
###begin article-title 109
###xml 72 76 <span type="species:ncbi:10116">rats</span>
Selective immunolesioning of the basal forebrain cholinergic neurons in rats: Effect on attention using the 5-choice serial reaction time task
###end article-title 109
###begin article-title 110
Selective deficits in attentional performance on the 5-choice serial reaction time task following pedunculopontine tegmental nucleus lesions
###end article-title 110
###begin article-title 111
Brain cholinergic vulnerability: Relevance to behavior and disease
###end article-title 111
###begin article-title 112
Enhanced plasma DHEAS, brain acetylcholine and memory mediated by steroid sulfatase inhibition
###end article-title 112
###begin article-title 113
Enhancement of hippocampal acetylcholine release by the neurosteroid dehydroepiandrosterone sulfate: An in vivo microdialysis study
###end article-title 113
###begin article-title 114
Molecular mechanisms and binding site locations for noncompetitive antagonists of nicotinic acetylcholine receptors
###end article-title 114
###begin article-title 115
Neurosteroids and cholinergic systems: Implications for sleep and cognitive processes and potential role of age-related changes
###end article-title 115
###begin article-title 116
Central nicotinic cholinergic systems: a role in the cognitive dysfunction in attention-deficit/hyperactivity disorder?
###end article-title 116
###begin article-title 117
Attention-deficit/hyperactivity disorder: Neurophysiology, information processing, arousal and drug development
###end article-title 117
###begin article-title 118
Sulfated and unsulfated steroids modulate gamma-aminobutyric acidA receptor function through distinct sites
###end article-title 118
###begin article-title 119
###xml 33 37 <span type="species:ncbi:10090">mice</span>
Effects on fear reactivity in XO mice are due to haploinsufficiency of a non-PAR X gene: Implications for emotional function in Turner's syndrome
###end article-title 119
###begin article-title 120
###xml 160 164 <span type="species:ncbi:10116">rats</span>
Effects of transient inactivation of the subthalamic nucleus by local muscimol and APV infusions on performance on the five-choice serial reaction time task in rats
###end article-title 120
###begin article-title 121
Molecular regulation of cognitive functions and developmental plasticity: Impact of GABAA receptors
###end article-title 121
###begin article-title 122
###xml 63 68 <span type="species:ncbi:10090">mouse</span>
Role of Ca2+ ions in nicotinic facilitation of GABA release in mouse thalamus
###end article-title 122
###begin article-title 123
Molecular genetics of attention
###end article-title 123
###begin article-title 124
Association study of the nicotinic acetylcholine receptor alpha4 subunit gene, CHRNA4, in attention-deficit hyperactivity disorder
###end article-title 124
###begin article-title 125
Mutational analysis of the nicotinic acetylcholine receptor alpha 4 subunit gene in attention deficit/hyperactivity disorder: Evidence for association of an intronic polymorphism with attention problems
###end article-title 125
###begin article-title 126
Nicotinic alpha 7 receptor clusters on hippocampal GABAergic neurons: Regulation by synaptic activity and neurotrophins
###end article-title 126
###begin article-title 127
###xml 59 63 <span type="species:ncbi:10090">mice</span>
Impaired performance of alpha7 nicotinic receptor knockout mice in the five-choice serial reaction time task
###end article-title 127
###begin article-title 128
Association of the steroid sulfatase (STS) gene with attention deficit hyperactivity disorder
###end article-title 128
###begin p 129
###xml 7 8 7 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 131 134 131 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sts</italic>
###xml 11 15 <span type="species:ncbi:10090">mice</span>
In 39,XY*O mice, an end-to-end fusion of the X and Y chromosome pseudo-autosomal regions results in deletion of both copies of the Sts gene.
###end p 129
###begin p 130
###xml 278 281 278 281 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A)</bold>
###xml 328 331 328 331 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B)</bold>
###xml 453 454 453 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 462 465 462 465 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(C)</bold>
###xml 600 601 600 601 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
Effects of dehydroepiandrosterone sulfate (DHEAS) administration on behavioral indices of attention during a 5-choice serial reaction time task manipulation in which stimulus durations were reduced. The drug treatment did not significantly affect the number of trials performed (A) or accuracy at any value of stimulus duration (B). However, DHEAS did result in fewer omissions at the shortest, and therefore, most attentionally demanding, time point (*p < .05) (C). There were no significant effects of the treatment on the latency taken to make at correct choice at any value of stimulus duration (D).
###end p 130
###begin p 131
###xml 314 317 314 317 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A)</bold>
###xml 363 366 363 366 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B)</bold>
###xml 511 512 511 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 571 574 571 574 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(C)</bold>
###xml 605 608 605 608 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(D)</bold>
###xml 742 745 742 745 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(E)</bold>
Effects of steroid sulfatase inhibition by COUMATE administration on behavioral indices of attention during 5-choice (5-CSRTT) and 1-choice serial reaction time task (1-CSRTT) manipulations in which stimulus durations were reduced. The drug treatment did not affect total number of trials performed in the 5-CSRTT (A) but did have significant effects on accuracy (B); this drug effect was present at all stimulus durations but was most marked at the most attentionally demanding stimulus duration of .25 sec (**p < .01). The drug manipulation had no effects on omissions (C) or correct response latencies (D). Importantly, when the attentional demands of the task were reduced in the 1-CSRTT, COUMATE administration had no effect on accuracy (E).
###end p 131
###begin p 132
###xml 11 14 11 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sts</italic>
###xml 32 33 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 271 274 271 274 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A)</bold>
###xml 310 313 310 313 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B)</bold>
###xml 354 355 354 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 402 403 402 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 411 414 411 414 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(C)</bold>
###xml 531 534 531 534 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(D)</bold>
###xml 610 611 610 611 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 712 715 712 715 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(E)</bold>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
###xml 394 398 <span type="species:ncbi:10090">mice</span>
###xml 614 618 <span type="species:ncbi:10090">mice</span>
###xml 651 655 <span type="species:ncbi:10090">mice</span>
Effects of Sts gene loss in 39,XY*O mice on behavioral indices of attention during 5-choice (5-CSRTT) and 1-choice serial reaction time task (1-CSRTT) manipulations in which stimulus durations were reduced. The two groups performed equal numbers of trials in the 5-CSRTT (A) and to the same degree of accuracy (B). At the shortest stimulus duration, 39,XY*O mice omitted more trials than 40,XY mice (**p < .01) (C). No effects of the gene manipulation were observed on correct response latencies for any value of stimulus duration (D). When the attentional demands of the task were reduced in the 1-CSRTT, 39,XY*O mice performed equivalently to 40,XY mice in terms of omissions at the shortest stimulus duration (E).
###end p 132
###begin p 133
###xml 11 14 11 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sts</italic>
###xml 32 33 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 267 268 267 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
###xml 271 275 <span type="species:ncbi:10090">mice</span>
###xml 318 322 <span type="species:ncbi:10090">mice</span>
Effects of Sts gene loss in 39,XY*O mice on an index of motor impulsivity (premature responses) on a 5-choice serial reaction time task (5-CSRTT) manipulation in which the intertrial interval (ITI) between trial initiation and stimulus presentation was extended. 39,XY*O mice made fewer premature responses than 40,XY mice for all values of ITI.
###end p 133
###begin p 134
###xml 76 79 76 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sts</italic>
###xml 92 93 92 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 184 187 184 187 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A)</bold>
###xml 197 198 197 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</sup>
###xml 386 389 386 389 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B)</bold>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
###xml 201 205 <span type="species:ncbi:10090">mice</span>
###xml 252 256 <span type="species:ncbi:10090">mice</span>
Effects of acute inhibition of steroid sulfatase by COUMATE, or loss of the Sts gene in 39,XY*O mice, on locomotor activity. COUMATE administration had no effect on locomotor activity (A). The 39,XY*O mice showed equivalent levels of activity to 40,XY mice on being placed in a novel environment, and both groups habituated to the environment equally over 3 consecutive days of testing (B).
###end p 134
###begin p 135
Baseline Performance on the 5-Choice Serial Reaction Time Task
###end p 135
###begin p 136
Baseline Performance on the 1-Choice Serial Reaction Time Task
###end p 136

